Home Cart Sign in  
Chemical Structure| 130370-60-4 Chemical Structure| 130370-60-4

Structure of Batimastat
CAS No.: 130370-60-4

Chemical Structure| 130370-60-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Batimastat is a potent broad spectrum MMP inhibitor with IC50 of 3, 4, 4, 6, and 20 nM for MMP-1, MMP-2, MMP-9, MMP-7 and MMP-3, respectively.

Synonyms: BB94

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Batimastat

CAS No. :130370-60-4
Formula : C23H31N3O4S2
M.W : 477.64
SMILES Code : O=C(NO)[C@@H](CSC1=CC=CS1)[C@@H](CC(C)C)C(N[C@@H](CC2=CC=CC=C2)C(NC)=O)=O
Synonyms :
BB94
MDL No. :MFCD00866533
InChI Key :XFILPEOLDIKJHX-QYZOEREBSA-N
Pubchem ID :5362422

Safety of Batimastat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • MMP

    MMP-7, IC50:4 nM

    MMP-1, IC50:3 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
CHO (7W cells) 2.6 μM overnight To evaluate the capability to inhibit α-secretase activity and confirm selectivity for ADAMs, with results showing indistinguishable inhibition and no significant toxicity to cells. PMC4720558
Zebrafish embryos 5 mM 48 hours Batimastat effectively reduced the expansion of scleral diameter in zebrafish embryos with an inhibition rate of 1.7%. PMC7941086
HL-60 cells 1-10 µM 72 hours BB-94 decreases cell viability and density in a dose-, time-, administration-scheme-, and cell-line-dependent manner. PMC11050270
NB-4 cells 1-10 µM 72 hours BB-94 decreases cell viability and density in a dose-, time-, administration-scheme-, and cell-line-dependent manner. PMC11050270
F36-P cells 1-10 µM 72 hours BB-94 decreases cell viability and density in a dose-, time-, administration-scheme-, and cell-line-dependent manner. PMC11050270
H929 cells 1-10 µM 72 hours BB-94 decreases cell viability and density in a dose-, time-, administration-scheme-, and cell-line-dependent manner. PMC11050270
IMC cells 1-10 µM 72 hours BB-94 did not show an impact on cell viability and only induced a small reduction in cell density. PMC11050270

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Form-deprivation myopia model Eye drops 5 mM Twice daily for 28 days Batimastat significantly mitigated myopic shift and axial elongation in the form-deprivation myopia model and reduced scleral thinning and changes in collagen fibril diameter. PMC7941086

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.09mL

0.42mL

0.21mL

10.47mL

2.09mL

1.05mL

20.94mL

4.19mL

2.09mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories